查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1550586

去势抗性前列腺癌市场：依治疗类型、药物类别、给药途径、通路及地区

Castrate Resistant Prostate Cancer Market, By Therapy Type, By Drug Class, By Route of Administration, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 167 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球去势抗性前列腺癌市场规模为98亿美元，预计2031年将达175.1亿美元，2024年至2031年复合年增长率为8.6%。

报告范围 报告详情
基准年 2023年 2024年市场规模 98亿美元
实际资料 2019-2023 预测期 2024年至2031年
预测 2024-2031 年复合年增长率： 8.60% 2031年价值预测 175.1亿美元
图：2024 年去势抗性前列腺癌市场份额（按地区划分）
去势抗性前列腺癌市场-IMG1

全球去势抗性前列腺癌市场的成长是由全球前列腺癌盛行率上升所推动的。摄护腺癌是男性最常见的癌症之一。根据2020年美国癌症协会资料，美国报告了约191,930例前列腺癌新病例。儘管透过药物或手术治疗降低睪固酮水平或阻止其作用，但当癌症扩散并开始生长时，它被称为去势抗性前列腺癌（CRPC）。目前CRPC可用的治疗方法包括化疗、免疫疗法和放射线治疗。然而，抗药性的发展仍然是有效治疗晚期前列腺癌的主要挑战。对新药物标靶和治疗方法的持续研究可以克服抗治疗性并改善 CRPC 患者的治疗结果。

市场动态：

全球去势抗性前列腺癌市场的成长是由更容易患前列腺癌的老龄化人口的增加所推动的。联合国《2019年世界人口展望》资料显示，65岁以上人口预计将从2019年的7.03亿增加到2050年的15亿。此外，意识的提高和筛检率的提高加强了前列腺癌的早期检测，推动了市场成长。然而，与免疫疗法和标靶治疗方案相关的高治疗成本可能会阻碍市场成长。继续研究和开发克服抗药性的新机制可能为市场相关人员提供有希望的机会。开发负担得起的生物相似药可以降低治疗成本。

本研究的主要特点

  • 该报告对全球去势抗性前列腺癌市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，了解全球去势抗性前列腺癌市场的主要企业概况。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球去势抗性前列腺癌市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球去势抗性前列腺癌市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球去势抗性前列腺癌市场 - 冠状病毒（COVID-19）大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球去势抗性前列腺癌市场，依治疗类型，2019-2031

  • 荷尔蒙疗法
  • 免疫疗法
  • 化疗
  • 放射治疗

第六章全球去势抗性前列腺癌市场，依药物类别，2019-2031

  • 抗癌药物
  • 非类固醇抗雄激素
  • 皮质类固醇
  • 微管抑制剂
  • 其他的

第7章全球去势抗性前列腺癌市场，依通路，2019-2031

  • 医院药房
  • 零售药房
  • 网路药房

第 8 章 全球去势抗性前列腺癌市场，依给药途径，2019-2031 年

  • 口服
  • 可注射的

第9章2019-2031年全球去势抗性前列腺癌市场（按地区）

  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东

第10章竞争格局

  • 公司简介
    • Trelleborg Sealing Solutions
    • Freudenberg Group
    • Parker Hannifin Corp
    • Saint-Gobain
    • Bal Seal Engineering, Inc.
    • Flexan
    • Marco Rubber &Plastics
    • Morgan Polymer Seals
    • Minnesota Rubber and Plastics
    • Precision Associates, Inc.
    • IDEX Health &Science LLC
    • Apple Rubber Products
    • Technetics Group
    • Sterne SAS
    • ResMed
    • West Pharmaceutical Services, Inc.

第十一章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第十二章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI4529

Global castrate resistant prostate cancer market is estimated to be valued at USD 9.80 Bn in 2024 and is expected to reach USD 17.51 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 9.80 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 8.60% 2031 Value Projection: US$ 17.51 Bn
Figure. Castrate Resistant Prostate Cancer Market Share (%), By Region 2024
Castrate Resistant Prostate Cancer Market - IMG1

Global castrate resistant prostate cancer market growth is driven by rising prevalence of prostate cancer worldwide. Prostate cancer is one of the commonly occurring cancers among men. According to the data from American Cancer Society in 2020, around 191,930 new cases of prostate cancer were reported in the U.S. Once the cancer has metastasized and started growing despite medical or surgical therapy to reduce testosterone levels or block its action, it is termed as castrate resistant prostate cancer (CRPC). Currently available treatment options for CRPC include chemotherapy, immunotherapy, radiation therapy, and others. However, development of resistance remains a major challenge in effectively managing this advanced stage of prostate cancer. Ongoing research for novel drug targets and therapeutic approaches can overcome treatment resistance and improve patient outcomes in CRPC.

Market Dynamics:

Global castrate resistant prostate cancer market growth is driven by rising geriatric population susceptible to developing prostate cancer. According to the data from UN World Population Prospects 2019, the number of people aged 65 years or above is projected to grow from 703 million in 2019 to 1.5 billion in 2050 globally. Increasing awareness and screening rates have also augmented the early detection of prostate cancer, thus, driving the market growth. However, high treatment costs associated with immunotherapy and targeted therapy regimens can hamper the market growth. Ongoing research to develop novel mechanisms for overcoming drug resistance can offer promising opportunities for market players. Development of affordable biosimilars can reduce treatment costs.

Key Features of the Study:

  • This report provides in-depth analysis of the global castrate resistant prostate cancer market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global castrate resistant prostate cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson, Astellas Pharma, Sanofi, Dendreon, Bayer, and others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global castrate resistant prostate cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global castrate resistant prostate cancer market

Detailed Segmentation-

  • By Therapy Type
    • Hormonal Therapy
    • Immunotherapy
    • Chemotherapy
    • Radiotherapy
  • By Drug Class
    • Antineoplastic
    • Non-steroidal Antiandrogen
    • Corticosteroids
    • Microtubule Inhibitor
    • Others
  • By Route of Administration
    • Oral
    • Injectable
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Trelleborg Sealing Solutions
    • Freudenberg Group
    • Parker Hannifin Corp
    • Saint-Gobain
    • Bal Seal Engineering, Inc.
    • Flexan
    • Marco Rubber & Plastics
    • Morgan Polymer Seals
    • Minnesota Rubber and Plastics
    • Precision Associates, Inc.
    • IDEX Health & Science LLC
    • Apple Rubber Products
    • Technetics Group
    • Sterne S.A.S.
    • ResMed
    • West Pharmaceutical Services, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Therapy Type
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Castrate Resistant Prostate Cancer Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Castrate Resistant Prostate Cancer Market, By Therapy Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hormonal Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Immunotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Chemotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Radiotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Castrate Resistant Prostate Cancer Market, By Drug Class, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Antineoplastic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Non-steroidal Antiandrogen
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Corticosteroids
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Microtubule Inhibitor
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Castrate Resistant Prostate Cancer Market, By Distribution Channel, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Castrate Resistant Prostate Cancer Market, By Route of Administration, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Injectable
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Castrate Resistant Prostate Cancer Market, By Region, 2019 - 2031, (USDBn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Company Profiles
    • Trelleborg Sealing Solutions
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Freudenberg Group
    • Parker Hannifin Corp
    • Saint-Gobain
    • Bal Seal Engineering, Inc.
    • Flexan
    • Marco Rubber & Plastics
    • Morgan Polymer Seals
    • Minnesota Rubber and Plastics
    • Precision Associates, Inc.
    • IDEX Health & Science LLC
    • Apple Rubber Products
    • Technetics Group
    • Sterne S.A.S.
    • ResMed
    • West Pharmaceutical Services, Inc.

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact